• Dr. Black Presentation at Google Solve for X

    Dr. Black discussing the challenges of Alzheimer’s and some potential solutions, at Google’s Solve for X event.

    Keith
  • Our Mission

    NeuroVision is developing a noninvasive, quick, and inexpensive retinal imaging test for the early detection and diagnosis of Alzheimer’s disease. Our proprietary technology allows us to image amyloid beta plaque (the hallmark sign of the disease) in the retina.

    in vivo lableing of AB Plaques
  • Research

    Animal models, human cadaver studies, and human clinical trials confirm the presence of amyloid beta plaque in the human retina. Ongoing clinical trials demonstrate separation of Alzheimer’s and MCI patients from healthy controls.

    iStock_000002991298_Small
  • Retinal Imaging Test

    Our goal is to provide clinicians with a simple, objective retinal imaging test in an office setting that enables detection of amyloid beta plaques and monitoring of patients over time.

    DSC_1995
  • Alzheimer’s Disease

    Alzheimer’s begins creating changes in the brain (buildup of amyloid) as many as 20 years before symptoms occur. Early detection is key.

    iStock_000014034005_Small

CNet – Australian scientists developing early detection test for Alzheimer’s

CNet reports on Neurovision Imaging’s trial with CSIRO, and interviews Shaun Frost....

15th Jul
sfaibl1

CBS News Report – Eye test may be able to detect Alzheimer’s decades before onset

NEW YORK - More than 5 million Americans currently have Alzheimer’s disease. That...

15th Jul
cbsnews1

Wall Street Journal Reports on Neurovision Imaging’s Research

From the Wall Street Journal, July 13, 2014 COPENHAGEN—Efforts to detect Alzheimer’s...

15th Jul
BN-DR108_0713re_G_20140713111845

NeuroVision Imaging Eye Test Shows Potential for Early Detection of Changes Associated with Alzheimer’s Disease in Clinical Study

“If longitudinal studies demonstrate that our test can detect changes in retinal plaque over a short period of time, we see great potential for using the technology not just for early detection, but also for measuring response to therapy,” said NeuroVision CEO Steven Verdooner.

14th Jul
R3D

Dr. Black interviewed on KCET

Dr. Black  describes the NeuroVisionImaging Alzheimer’s test.  

11th Jul
kb1

CNN Reports on New Retinal Imaging Test for Alzheimer’s

CNN’s Dr. Sanjay Gupta takes a look at NeuroVision Imaging’s retinal imaging...

19th Aug
CNN Health

NeuroVision Eye Test Part of Major Alzheimer’s Trial

Researchers are trialing NVI technology for early identification of Alzheimer’s Disease. More...

06th Jun
NVISpots_Logo

Dr. Keith Black featured in Discoveries Magazine

Q&A with Dr. Keith Black on Alzheimer’s disease. Read the full article...

04th Jan
KB_2

Alzheimer’s research targets amyloid beta plaque in the retina

Learn more about the basic science.

02nd Jan
Labeling

Alzheimer’s Disease Facts and Figures

Learn more about Alzheimer's disease

02nd Jan
AD_Cover
Pages:12»